Xencor (XNCR) Cash & Equivalents (2013 - 2026)
Xencor (XNCR) reported Cash & Equivalents of $14.2 million for Q1 2026, down 64.28% year-over-year from $39.7 million in Q1 2025, and down 73.79% quarter-over-quarter from $54.1 million in Q4 2025.
Xencor (XNCR) Cash & Equivalents (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Cash & Equivalents data on file, last reported at $14.2 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $14.2 million, down 64.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 million (down 64.28% YoY), and the FY2025 annual result was $54.1 million, up 32.29% from the prior year.
- Cash & Equivalents declined to $14.2 million in Q1 2026 per XNCR's latest filing, from $54.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $78.3 million in Q1 2022 and troughed at $14.2 million in Q1 2026.
- A 5-year average of $44.7 million and a median of $44.4 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents surged 44.44% in 2025, then plunged 64.28% in 2026.
- A 5-year view of Cash & Equivalents shows it stood at $53.9 million in 2022, then fell by 0.28% to $53.8 million in 2023, then dropped by 24.01% to $40.9 million in 2024, then soared by 32.29% to $54.1 million in 2025, then sank by 73.79% to $14.2 million in 2026.
- Business Quant data shows XNCR's Cash & Equivalents at $14.2 million in Q1 2026, $54.1 million in Q4 2025, and $28.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.17 Mn |
| Dec 31, 2025 | 54.07 Mn |
| Sep 30, 2025 | 28.29 Mn |
| Jun 30, 2025 | 44.44 Mn |
| Mar 31, 2025 | 39.68 Mn |
| Dec 31, 2024 | 40.88 Mn |
| Sep 30, 2024 | 29.03 Mn |
| Jun 30, 2024 | 30.77 Mn |
| Mar 31, 2024 | 31.03 Mn |
| Dec 31, 2023 | 53.79 Mn |
| Sep 30, 2023 | 52.73 Mn |
| Jun 30, 2023 | 34.71 Mn |
| Mar 31, 2023 | 72.39 Mn |
| Dec 31, 2022 | 53.94 Mn |
| Sep 30, 2022 | 52.65 Mn |
| Jun 30, 2022 | 49.41 Mn |
| Mar 31, 2022 | 78.27 Mn |
| Dec 31, 2021 | 143.48 Mn |
| Sep 30, 2021 | 41.20 Mn |
| Jun 30, 2021 | 115.84 Mn |